Brain Pharmacokinetics of Two Prolyl Oligopeptidase Inhibitors, JTP-4819 and KYP-2047, in the Rat

A Novel Proteolytic Cascade Generates an Extracellular Matrix-Derived Chemoattractant in Chronic Neutrophilic Inflammation

(2014) A. Gaggar et al.   JOURNAL OF IMMUNOLOGY

GAP43 shows partial co-localisation but no strong physical interaction with prolyl oligopeptidase

(2010) Zoltán Szeltner et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Comparison of in vitro cell models in predicting in vivo brain entry of drugs

(2010) Jenni J. Hakkarainen et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Inhibitors of Prolyl Oligopeptidases for the Therapy of Human Diseases: Defining Diseases and Inhibitors

(2010) Janice Lawandi et al.   JOURNAL OF MEDICINAL CHEMISTRY

Combination of snap freezing, differential pH two-dimensional reverse-phase high-performance liquid chromatography, and iTRAQ technology for the peptidomic analysis of the effect of prolyl oligopeptidase inhibition in the rat brain

(2009) Jofre Tenorio-Laranga et al.   ANALYTICAL BIOCHEMISTRY

Different Effects of Scopolamine and Inhibition of Prolyl Oligopeptidase on Mnemonic and Motility Functions of Young and 8- to 9-Month-Old Rats in the Radial-Arm Maze

(2009) Iida Peltonen et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity

(2009) Elena Di Daniel et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Cellular and subcellular distribution of rat brain prolyl oligopeptidase and its association with specific neuronal neurotransmitters

(2008) Timo T. Myöhänen et al.   JOURNAL OF COMPARATIVE NEUROLOGY

Prolyl oligopeptidase stimulates the aggregation of α-synuclein

(2008) Inger Brandt et al.   PEPTIDES